A Phase I Study of Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Artesunate (Primary)
- Indications Anal dysplasia; Anal intraepithelial neoplasia; Human papillomavirus infections
- Focus Adverse reactions
- Acronyms ART-AIN
- 02 Nov 2021 Status changed from active, no longer recruiting to completed.
- 09 Apr 2021 Planned primary completion date changed from 30 Apr 2021 to 31 Oct 2021.
- 26 Jan 2021 Planned End Date changed from 31 Jul 2021 to 31 Oct 2021.